Replies to post #281465 on Innovation Pharmaceuticals Inc (IPIX)

[loanranger]

"We believe that targeted delivery to the colon is part-and-parcel to the potential future success of Brilacidin as a new oral inflammatory bowel disease drug."

Haven't previous BDD trials already shown that they can do that?
https://www.bddpharma.com/copy-of-controlled-release

What makes the IPIX trial different?